Haematotoxicity during peptide receptor radionuclide therapy: Baseline parameters differences and effect on patient's therapy course.

Haematotoxicity during peptide receptor radionuclide therapy: Baseline parameters differences and effect on patient's therapy course.

Mostrar otras versiones (1)

<h4>Background</h4>Mainly severe (CTCAE grade 3-4) haematotoxicity during peptide receptor radionuclide therapy (PRRT) is reported in literature due to major clinical impact, however moderate (CTCAE grade 2) haematotoxicity is common and could affect therapy management. The aim of this s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daphne M V de Vries-Huizing, Michelle W J Versleijen, Michiel Sinaasappel, Iris Walraven, Martine M Geluk-Jonker, Margot E T Tesselaar, Jeroen J M A Hendrikx, Berlinda J de Wit-van der Veen, Marcel P M Stokkel
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/49f0ebf26a2d4259ac04d82f4bf2bdd1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Search Result 1
Haematotoxicity during peptide receptor radionuclide therapy: Baseline parameters differences and effect on patient’s therapy course
Enlace del recurso
article
Agregar a favoritos
Guardado en:
Mostrar todas las versiones(2)

Ejemplares similares